Evidence map›Paper›PMID 39606595›Full record

ArticlePostepy dermatologii i alergologii2024

Association of the expression of Bcl-2 and Ki-67 prognostic markers and apoptotic index with biological behaviour in aggressive and non-aggressive non-melanoma eyelid skin cancer.

Zuzana Prídavková, Lukáš Plank, Peter Žiak, Juraj Halička, Karolína Benca-Kapitánová, Rastislav Vida, Vladimír Bartoš

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Postepy dermatologii i alergologii, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zuzana PrídavkováUVEA Eye Clinic s. r. o., Martin, Slovakia.
Lukáš PlankDepartment of Pathological Anatomy, Jessenius Faculty of Medicine and University Hospital in Martin, Comenius University in Bratislava, Slovakia.
Peter ŽiakUVEA Eye Clinic s. r. o., Martin, Slovakia.
Juraj HaličkaUVEA Eye Clinic s. r. o., Martin, Slovakia.
Karolína Benca-KapitánováUVEA Eye Clinic s. r. o., Martin, Slovakia.
Rastislav VidaUVEA Eye Clinic s. r. o., Martin, Slovakia.
Vladimír BartošMartin's Biopsy Center, Ltd., Martin, Slovakia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Prognostic biomarkers facilitate the identification of high-risk tumours. Aim: To evaluate the association of Bcl-2 protein and Ki-67 antigen expression and the apoptotic index with biological behaviour of non-melanoma eyelid tumours. Material and methods: Combined analysis of retrospective and prospective study of data from two centres over a period from 2008 to 2023 on histologically confirmed malignant non-melanoma eyelid tumours without any age limitation. Selected prognostic markers related to the aggressive or non-aggressive tumour types were evaluated. Results: The study cohort included 68 patients with 70 non-melanoma eyelid tumours ( Conclusions: New information on cancer biomarkers in non-melanoma eyelid skin carcinoma contributes to choosing a correct therapy with achieving good aesthetic results and a good survival rate.

Indexed as

apoptotic indexbasal cell carcinomaBcl-2 proteinKi-67 antigenonco-ophthalmology

Identifiers

PMID39606595
PMCPMC11589630

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.